Fate Therapeutics CEO J Wolchko's 2018 pay jumps 171% to $3.5M
Fate Therapeutics reports 2018 executive compensation
By ExecPay News
Published: March 22, 2019
Fate Therapeutics reported fiscal year 2018 executive compensation information on March 22, 2019.
In 2018, four executives at Fate Therapeutics received on average a compensation package of $2.2M, a 125% increase compared to previous year.
Average pay of disclosed executives at Fate Therapeutics
J. Scott Wolchko, Chief Executive Officer, received $3.5M in total, which increased by 171% compared to 2017. 78% of Wolchko's compensation, or $2.8M, was in option awards. Wolchko also received $258K in non-equity incentive plan and $516K in salary.
Bahram Valamehr, Chief Development Officer, received a compensation package of $2.6M. 83% of the compensation package, or $2.1M, was in option awards.
Cindy R. Tahl, General Counsel, earned $1.4M in 2018.
Daniel D. Shoemaker, Chief Scientific Officer, received $1.3M in 2018, which increases by 67% compared to 2017.
Related executives
You may also like
Source: SEC filing on March 22, 2019.